143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY.
Saved in:
| Title: | 143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY. |
|---|---|
| Authors: | Elliott, Jessie1 (AUTHOR), Klevebro, Fredrik1 (AUTHOR), Mantziari, Styliani2 (AUTHOR), Markar, Sheraz R3 (AUTHOR), Goense, Lucas4 (AUTHOR), Johar, Asif5 (AUTHOR), Lagergren, Pernilla6 (AUTHOR), Zaninotto, Giovanni7 (AUTHOR), Hillegersberg, Richard8 (AUTHOR), Henegouwen, Mark I Berge9 (AUTHOR), Schäfer, Markus10 (AUTHOR), Nilsson, Magnus (AUTHOR), Hanna, George B (AUTHOR), Reynolds, John V (AUTHOR), group, ENSURE study (AUTHOR) |
| Source: | Diseases of the Esophagus. 2023 Supplement, Vol. 36, p1-2. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11208694 |
|---|---|
| DOI: | 10.1093/dote/doad052.024 |
